Show simple item record

Severe macrothrombocytopenia with platelet CD9 deficiency responsive to romiplostim

dc.contributor.authorSeddiq, Marjilla
dc.contributor.authorGadgeel, Manisha
dc.contributor.authorPersaud, Yogindra
dc.contributor.authorLafferty, Jennifer
dc.contributor.authorSavaşan, Süreyya
dc.date.accessioned2020-09-02T14:59:23Z
dc.date.availableWITHHELD_12_MONTHS
dc.date.available2020-09-02T14:59:23Z
dc.date.issued2020-08
dc.identifier.citationSeddiq, Marjilla; Gadgeel, Manisha; Persaud, Yogindra; Lafferty, Jennifer; Savaşan, Süreyya (2020). "Severe macrothrombocytopenia with platelet CD9 deficiency responsive to romiplostim." British Journal of Haematology 190(4): e239-e242.
dc.identifier.issn0007-1048
dc.identifier.issn1365-2141
dc.identifier.urihttps://hdl.handle.net/2027.42/156447
dc.publisherWiley Periodicals, Inc.
dc.subject.othersevere
dc.subject.otherbleeding
dc.subject.otherplatelet CD9 deficiency
dc.subject.otherromiplostim
dc.subject.othermacrothrombocytopenia
dc.titleSevere macrothrombocytopenia with platelet CD9 deficiency responsive to romiplostim
dc.typeArticle
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelOncology and Hematology
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/156447/2/bjh16812_am.pdfen_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/156447/1/bjh16812.pdfen_US
dc.identifier.doi10.1111/bjh.16812
dc.identifier.sourceBritish Journal of Haematology
dc.identifier.citedreferenceLambert MP. Inherited platelet disorders: a modern approach to evaluation and treatment. Hematol Oncol Clin North Am. 2019; 33: 471 - 87.
dc.identifier.citedreferenceBeltrame MP, Malvezzi M, Zanis J, Pasquini R. Flow cytometry as a tool in the diagnosis of bernard- Soulier syndrome in brazilian patients. Platelets. 2009; 20: 229 - 34.
dc.identifier.citedreferenceBoeckelmann D, Hengartner H, Greinacher A, Nowak- Göttl U, Sachs UJ, Peter K, et al. Patients with Bernard- Soulier syndrome and different severity of the bleeding phenotype. Blood Cell Mol Dis. 2017; 67: 69 - 74.
dc.identifier.citedreferenceNoris P, Biino G, Pecci A, Civaschi E, Savoia A, Seri M, et al. Platelet diameters in inherited thrombocytopenias: analysis of 376 patients with all known disorders. Blood. 2014; 124: 4 - 11.
dc.identifier.citedreferenceJennings LK, Crossno JT, Fox CF, White MM, Green CA. Platelet p24/CD9, a Member of the Tetraspanin Family of Proteins. Ann NY Acad Sci. 1994; 714: 175 - 84.
dc.identifier.citedreferenceSlupsky JR, Kamiguti AS, Rhodes NP, Cawley JC, Shaw ARE, Zuzel M. The platelet antigens CD9, CD42 and integrin α(IIb)β(IIIa) can be topographically associated and transduce functionally similar signals. Eur J Biochem. 1997; 244: 168 - 75.
dc.identifier.citedreferenceCharrin S, Jouannet S, Boucheix C, Rubinstein E. Tetraspanins at a glance. J Cell Sci. 2014; 127: 3641 - 8.
dc.identifier.citedreferenceZaninetti C, Gresele P, Bertomoro A, Klersy C, de Candia E, Veneri D, et al. Eltrombopag for the treatment of inherited thrombocytopenias: a phase II clinical trial. Haematologica. 2020; 105: 820 - 8.
dc.identifier.citedreferenceRodeghiero F, Pecci A, Balduini CL. Thrombopoietin receptor agonists in hereditary thrombocytopenias. J Thromb Haemost. 2018; 16: 1700 - 10.
dc.identifier.citedreferenceQiao J, Davis AK, Morel- Kopp MC, Ward CM, Gardiner EE, Andrews RK. Low levels of CD9 coincidental with a novel nonsense mutation in glycoprotein Ibβ in a patient with Bernard- Soulier syndrome. Ann Hematol. 2015; 94: 2069 - 71.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.